Nurturing the psychedelic ecosystem, providing you with research-based education, access to vetted providers, and membership in our global community.

Joined January 2016
This post hit 2M+ views. People aren't just curious about psychedelics... They're hungry for the science behind brain health and neuroplasticity. Stigma can't compete with two-photon microscopy showing new dendritic spines forming in living brains.
We can now watch psilocybin grow new brain connections in real time. Not metaphorically. Not "neuroplasticity" as a vague buzzword. Actual, physical structures — dendritic spines — sprouting from cortical neurons within 24 hours of a single dose. A team at Yale used chronic two-photon microscopy to image individual dendritic spines on layer 5 pyramidal neurons in the medial frontal cortex of living mice. Before psilocybin. After psilocybin. Same neurons. Same spines. Day after day. And here's what they found: A single dose of psilocybin produced a ~10% increase in spine density and spine size. New spines began forming within 24 hours. Most of these new connections were still there a month later. That last part matters most. Psilocybin has a half-life of about 3 hours. The molecule is gone by dinner. But the structural changes it triggers persist for at least 34 days (and likely far longer). This is the biological explanation for something clinicians have observed for years: a single psilocybin session producing therapeutic benefits that last months. The drug disappears, but the architecture it built does not. There's a critical mechanistic detail. When researchers pre-treated with ketanserin — a 5-HT2A receptor antagonist — the spine growth was completely blocked. This confirms that structural remodeling depends on activation of the serotonin 2A receptor. The same receptor responsible for the psychedelic experience itself. A 2025 follow-up from the same lab went further. Using rabies tracing to map brain-wide inputs to these new spines, they discovered psilocybin's rewiring is network-specific. It selectively strengthens inputs from perceptual and default mode network regions, the same networks implicated in self-referential processing, rumination, and depression. It doesn't just grow connections randomly. It grows the RIGHT ones. Here's what this means for practitioners: The window after a psychedelic experience isn't just psychological. It's structural. New dendritic spines form and stabilize in the days and weeks following a session. Integration practices — therapy, journaling, somatic work, meditation, breathwork — aren't just processing insights. They may be reinforcing which of these new physical connections survive. You're not just supporting someone's mental model. You're supporting their neural architecture. Think about what that reframes. The integration period isn't a nice-to-have. It's a biological imperative. Those new spines either stabilize into lasting connections or get pruned. The environment, practices, and support during that window may determine which. We're not just learning that psilocybin works. We're watching exactly how it works, at the level of individual synapses. The implications for how we design protocols, structure integration, and time follow-up sessions are enormous. What do you make of this research? Is psilocybin the miracle drug that science makes it out to be?
5
18
1
117
9,716
Colorado is planning to medicalize ibogaine within its new legal system. How does one regulate such powerful medicine within the our current healthcare systems? They are fundamentally incompatible. Colorado must pioneer new systems that support transformative work.
6
5
48
1,859
The future of microdosing isn’t just about “mental health.” It’s about physiological well-being. San Pedro microdoses, combined with somatic tools, mark the next evolution in nervous system healing, redefining microdosing as a modality for embodied transformation.
3
6
45
2,154
Psychedelics don’t change your life. Your nervous system’s response to psychedelics does. That's why regulation—before, during, and after—is the future.
13
19
2
138
5,909
The first Bicycle Day wasn’t a celebration. It was a rupture. One man cracked the shell of consensus reality, and biked headfirst into God. No sitter. No Spotify. Just 250μg and fate.
4
20
1
176
10,938
A portal is opening. 6 days in the Costa Rican jungle. 1 psilocybin ceremony. 1 microdosing immersion. Daily integration + connection. For the visionary. The seeker. The leader. Not a retreat but a rite of passage. Will you step through?
8
1
24
1,369
Microdosing psychedelics isn’t “woo.” It’s neuroplasticity, amplified. Neurogenesis, initiated. Agency, reclaimed.
13
13
119
2,729
Psychedelics were never meant to be a solo sport. The power of group ceremonies is older than civilization itself. The modern obsession with 1:1 therapy is missing the point.
20
6
1
112
4,169
Psychedelics aren’t just for fixing broken minds, hearts, and souls. They’re for expanding them, helping them to stretch into their greatest expression. Healing is step one but what comes after?
13
8
1
73
2,960
Psychedelics made their way into therapy. Next stop? The workplace. When CEOs & founders can openly microdose, without fear of reprisal, the business landscape will never be the same.
18
14
1
101
4,687
The psychedelics we know eg psilocybin, LSD, DMT - are just the tip of the iceberg. What happens when we start designing entirely new states of consciousness?
43
23
4
276
19,412
Steve Jobs said LSD made Apple possible. Now the founders of OpenAI and Neuralink are funding next-gen psychedelics. The singularity isn’t just AI, it’s understanding the fundamental nature of consciousness. And when and how we choose to merge with it.
38
42
4
304
14,010
AI and psychedelics will merge sooner than you think. Personalized trips, optimized integration, even digital hallucinations. The future is wild.
46
14
10
167
20,233
The biggest lesson psychedelics teach? How to hold paradox. Healing and dangerous. Scientific and mystical. Sacred and synthetic. What would you add?
43
11
102
5,987
Psychedelics are the door. Meditation is the key. Integration is the map.
22
24
5
265
7,006
The biggest lie about DMT is that it’s a drug. It’s not just another molecule, it’s a doorway and portal to landscapes beyond comprehension and logic. The question isn’t whether DMT takes you somewhere real. It’s whether this reality is the illusion.
19
16
3
200
6,284
The next phase of psychedelics isn’t medical, it’s cultural. Therapy is valuable, but healing isn’t just about curing depression. It’s about reimagining what life can be. The true impact of psychedelics won’t be in clinics. It’ll be in how we build the future.
23
28
2
192
5,528
The real question isn’t “Can AI be conscious?” It’s “Do humans even understand what consciousness is?” Psychedelics suggest we're only just beginning to unravel this mystery.
23
9
5
112
5,484
The psychedelic industry is being built by the same system psychedelics help you escape. These medicines teach autonomy, creativity, and self-healing, yet the industry pushes patents, regulations, and $3K therapy sessions. Who really benefits when healing becomes a product?
21
6
3
140
4,132
Psychedelics dismantle the brain's default mode network (DMN) our autopilot of control and conformity. What's often the result? Freedom from the illusions we mistake for reality.
10
18
3
169
4,910